The effect of low-molecular-weight heparin combined with amikacin on the coagulation function and bacterial clearance in the treatment of patients with severe senile pneumonia
- PMID: 36694771
- PMCID: PMC9842970
- DOI: 10.12669/pjms.39.1.6627
The effect of low-molecular-weight heparin combined with amikacin on the coagulation function and bacterial clearance in the treatment of patients with severe senile pneumonia
Abstract
Objective: To analyze the effect of the combined low-molecular-weight heparin (LMWH) and amikacin treatment on the bacterial clearance and changes in coagulation function in patients with severe pneumonia (SP).
Methods: A single-center retrospective observational study was conducted. Medical records of 526 elderly patients with SP admitted to the ICU Department of Shandong Provincial Third Hospital from February, 2018 to December, 2021 were reviewed and 342 patients were identified. The patients were divided into two groups according to the treatment records: the study group (175 patients received LMWH combined with amikacin) and the control group (167 patients received amikacin). Changes in coagulation indexes before and after the treatment, as well as bacterial clearance rate and clinical efficacy after the treatment were compared between the two groups.
Results: There was no significant difference in prothrombin time (PT), D-Dimer (D-D), antithrombin III (AT-III) and fibrinogen (FIB) levels between the two groups before the treatment (P>0.05). After the treatment, levels of PT, D-D and FIB in the two groups decreased and the level of AT-III increased(P<0.05). Levels of PT, D-D and FIB in the study group were lower, and the level of AT-III was higher (P<0.05) that n in the control group. Bacterial clearance rate in the study group was (86.19%), higher than that in the control group (72.25%) (P<0.05). The total clinical effective rate of the study group (93.14%) was significantly higher than that of the control group (79.04%) (P<0.05).
Conclusions: Combining LMWH with amikacin in the treatment of elderly SP patients can improve the coagulation function and bacterial clearance, can promote the recovery of patients and has a good clinical application value.
Keywords: Amikacin; Bacterial clearance; Low molecular weight heparin; Severe pneumonia.
Copyright: © Pakistan Journal of Medical Sciences.
Similar articles
-
[Small dose of low molecular weight heparin improves the prognosis of elderly patients with severe pneumonia: a Meta-analysis of 1 173 patients].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Jan;32(1):26-32. doi: 10.3760/cma.j.cn121430-20191008-00005. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 32148227 Chinese.
-
Correlations of coagulation indexes and inflammatory changes with the prognosis of lung cancer complicated with thromboembolic disease.J BUON. 2019 Mar-Apr;24(2):585-590. J BUON. 2019. PMID: 31128010
-
Clinical Efficacy of Conventional Heparin Anticoagulation Combined with Apixaban in the Treatment of Patients with Cerebral Venous Thrombosis and Its Effect on Serum D-Dimer and FIB Expression.Comput Math Methods Med. 2021 Dec 31;2021:4979210. doi: 10.1155/2021/4979210. eCollection 2021. Comput Math Methods Med. 2021. PMID: 35003321 Free PMC article. Clinical Trial.
-
Meta-Analysis of the Efficacy of Low Molecular Weight Heparin and Aspirin in the Treatment of Thrombosis During Pregnancy and Effects on Coagulation Function.Discov Med. 2023 Apr 1;35(175):104-115. doi: 10.24976/Discov.Med.202335175.11. Discov Med. 2023. PMID: 37105921 Review.
-
Coagulation Panel in Patients with SARS-CoV2 Infection (COVID-19).Ann Clin Lab Sci. 2020 May;50(3):295-298. Ann Clin Lab Sci. 2020. PMID: 32581015 Review.
Cited by
-
Non-Anticoagulant Activities of Low Molecular Weight Heparins-A Review.Pharmaceuticals (Basel). 2023 Sep 5;16(9):1254. doi: 10.3390/ph16091254. Pharmaceuticals (Basel). 2023. PMID: 37765064 Free PMC article. Review.
-
Plasma D-D and CRP as predictive indicators for mortality in elderly patients with severe pneumonia.Am J Transl Res. 2025 Jan 15;17(1):239-246. doi: 10.62347/GMQB3287. eCollection 2025. Am J Transl Res. 2025. PMID: 39959197 Free PMC article.
-
Network meta-analysis on 4 types of traditional Chinese medicine injections in the treatment of senile severe pneumonia.Medicine (Baltimore). 2024 Dec 27;103(52):e41060. doi: 10.1097/MD.0000000000041060. Medicine (Baltimore). 2024. PMID: 39969367 Free PMC article.
References
-
- Rukavishnikova SA, Akhmedov TA, Pushkin AS, Saginbaev UR, Piskunov DP, Volchkova EV. Features of the coefficient of variation of hematological indicators in persons of middle, elderly and senile age with pneumonia. Adv Gerontol Uspekhi Gerontol. 2021;34(1):102–106. - PubMed
-
- Niederman MS, Alder J, Bassetti M, Boateng F, Cao B, Corkery K, et al. Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE):a double-blind, randomised, placebo-controlled, phase 3, superiority trial. Lancet Infect Dis. 2020;20(3):330–340. doi:10.1016/S1473-3099(19)30574-2. - PubMed
-
- Shehzadi N, Hussain K, Khan MT, Salman M, Islam M. Evaluation of dynamics of derivatization and development of RP-HPLC method for the determination of amikacin sulphate. Pak J Pharm Sci. 2017;30(5):1767–1777. - PubMed
-
- Sharma L, Wu J, Patel V, Sitapara R, Rao NV, Kennedy TP, et al. Partially-desulfated heparin improves survival in Pseudomonas pneumonia by enhancing bacterial clearance and ameliorating lung injury. J Immunotoxicol. 2014;11(3):260–267. doi:10.3109/1547691X.2013.839587. - PubMed
LinkOut - more resources
Full Text Sources